< Back to catalogue
Bempedoic acid
August 4, 2026Dapagliflozin
August 4, 2026PHARMAZAC
Bempedoic acid + Ezetimibe
Bempedoic acid/Ezetimibe | Antihyperlipidemic | Business Development
| F.C. TABS (180+10)MG/TAB |
| F.C. TABS (180+10)MG/TAB |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | Under Development |
| THERAPEUTIC AREA |
